Stay updated on Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Sign up to get notified when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T15:56:14.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:29:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information related to chemotherapy and the introduction of a new term, 'Chemotherapy-induced Neutropenia', along with a version update to v2.15.0.
    Difference
    5%
    Check dated 2025-04-16T14:24:11.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:12:19.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-24T20:57:16.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:54:14.000Z thumbnail image

Stay in the know with updates to Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.